June 25th 2025
Solution is for patients suffering from severe ankle joint damage due to rheumatoid, post-traumatic, or degenerative arthritis
June 24th 2025
Product eliminates the need for needles, cuffs, and calibration.
June 23rd 2025
Voxi 5 delivers continuous flow oxygen at one to five liters per minute in a compact, quiet, and mobile design
June 20th 2025
Texas A&M and Humanate debut an emotionally intelligent AI assistant to ease clinic workloads. Its name is Cassie.
Tandem's t:slim X2 insulin pump now integrates with FreeStyle Libre 3, enhancing personalized diabetes management with real-time glucose data sharing.
Artedrone’s autonomous microrobot shows promise for stroke treatment in preclinical studies
Robotic removal of blood clots could dramatically change stroke care
Device designed to help the large population of patients suffering from ventricular tachycardia receives FDA designation
Adagio Medical Receives FDA Breakthrough Device Designation for its Cryoablation System that targets VT
Edwards Lifesciences wins CE mark for transfemoral mitral valve replacement system
Device can now be used in patients with symptomatic moderate-to-severe or severe mitral regurgitation who are not candidates for surgery or transcatheter edge-to-edge repair therapy.
Light-based technology developed for non-invasive glucose monitoring
RSP Systems achieves major milestone in non-invasive glucose monitoring technology
FQHC uses suite of AI tools to improve documentation and engagement
Oak Orchard Health taps AI tools from eClinicalWorks to boost efficiency, patient care
AI-powered device hits 500,000-scan milestone
Predictmedix cites growing role in health and safety for its device’s success
NeuroOne announces public offering, speeds up timeline for its trigeminal nerve ablation system
The company also expects to submit its application for 510(k) clearance for its OneRF Trigeminal Nerve Ablation System in May, sooner than expected.
Boston Scientific closes Bolt Medical acquisition, bolsters intravascular lithotripsy portfolio
Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.
New technology aims to standardize and modernize maternity care
FDA approves Dawes-Redman CTG analysis for U.S. use, enhancing fetal monitoring
Aidoc secures FDA clearance for AI-powered rib fracture detection
Triage solution is built on existing AI engine
AI-powered diabetic retinopathy screening shows promising results
Autonomous solution doesn’t require dilation in vast majority of cases
The state of AI diagnostics in health care: projected 24.6% CAGR through 2030
A market analysis report from Grand View Research projects the AI diagnostics market size to grow at a CAGR of 24.60% through 2030.